Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04100564
Other study ID # STUDY20110369
Secondary ID W81XWH- 16-D- 00
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date March 31, 2026

Study information

Verified date April 2024
Source University of Pittsburgh
Contact Jason Sperry, MD, MPH
Phone 412 802 8270
Email sperryjl@upmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Prehospital Airway Control Trial (PACT) is a proposed 5 year, open label, multi-center, stepped-wedge randomized trial comparing airway management strategies of prehospital trauma patients. The initial airway attempt will be randomized to either usual care (control) or a supraglottic airway management approach (intervention). The primary outcome will be 24 hour survival, with secondary outcomes to include survival to hospital discharge, expected clinical adverse events, airway management performance, ICU length of stay, ventilator days, incidence of ARDS, and incidence of ventilator associated pneumonia. Subjects will be enrolled across approximately 17 prehospital agencies at select LITES Network sites and will enroll a total of 2,009 subjects.


Recruitment information / eligibility

Status Recruiting
Enrollment 2009
Est. completion date March 31, 2026
Est. primary completion date March 31, 2025
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: 1. Traumatic injury requiring advanced airway management. Indicators of need for advanced airway management include: a) GCS<8, b) SpO2<90 despite supplemental oxygen, b) ETCO2>60 despite supplemental ventilation, or d) provider discretion. 2. Transport (or intended transport) to an enrolling LITES Trauma Center Exclusion Criteria: 1. < 15 years of age 2. Known pregnancy 3. Known prisoner 4. Initial advanced airway attempted by a non-PACT provider. 5. Cardiac Arrest without return of spontaneous circulation (ROSC) at the time of the intervention 6. Caustic substance ingestion 7. Airway burns 8. Objection to study voiced by subject or family member at the scene. Inclusion and exclusion criteria will be assessed based on information available at the time of enrollment, defined as the time at which enrolling agency provides positive pressure ventilation support. Although all reasonable efforts will be made by the emergency medical crew to either directly witness or obtain documentation of inclusion criteria, due to the nature of the emergency prehospital setting, there may be occasions where the emergency medical crew must rely on verbal report of inclusion criteria from referring hospital or emergency crew. In these instances, if, after subsequent review of outside hospital and/or ground crew documentation, it is determined that the subject did not meet inclusion criteria and/or met exclusion criteria, the subject will remain enrolled in the study based on the intention-to-treat principle. If a verbal report must be used in lieu of physical documentation or directly witnessing inclusion criteria, documentation of the verbal report will serve as the source documentation for determining eligibility. Verbal reports will be documented in the emergency medical record and will detail the information provided and by whom.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Supraglottic airway device
Initial advanced airway management with a supraglottic device
Other:
Standard airway management
Initial advanced airway management with standard care method

Locations

Country Name City State
United States Emory University Atlanta Georgia
United States John H. Stroger Hospital of Cook County Chicago Illinois
United States Mount Sinai Hospital Chicago Illinois
United States Northwestern Memorial Hospital Chicago Illinois
United States University of Chicago Chicago Illinois
United States East Carolina University Greenville North Carolina
United States University of Louisville Louisville Kentucky
United States Vanderbilt University Nashville Tennessee
United States Tulane University New Orleans Louisiana
United States Allegheny General Hospital Pittsburgh Pennsylvania
United States University of Pittsburgh Pittsburgh Pennsylvania
United States UPMC Pittsburgh Pennsylvania
United States Oregon Health & Science University Portland Oregon
United States Washington University at St. Louis Saint Louis Missouri

Sponsors (2)

Lead Sponsor Collaborator
Jason Sperry United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 24-hour survival From injury through 24 hours
Secondary Proportion of subjects that survive to hospital discharge From hospital admission through death or hospital discharge up to 30 days
Secondary Rate of first pass success of placement of advanced airway device At time of placement of device through confirmation of device placement
Secondary ICU length of stay Admission through 30 days or discharge
Secondary Ventilator days Admission through 30 days or discharge
Secondary Incidence of expected adverse events From initial airway management through first 24 hours of hospital admission
Secondary Incidence of need for rescue airway device At the time of placement of device through time of arrival to trauma bay
Secondary Incidence of hypoxia At the time of placement of device through time of arrival to trauma bay
Secondary Incidence of hypotension At the time of placement of device through time of arrival to trauma bay
See also
  Status Clinical Trial Phase
Completed NCT04567901 - GNRI and Influence of Nutrition on the Mortality of Trauma Patients
Enrolling by invitation NCT05794165 - Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism Phase 2
Not yet recruiting NCT06326827 - In'Oss™ (MBCP® Putty) Ortho
Recruiting NCT04403204 - ICG Fluorescence Imaging in Post-traumatic Infection
Completed NCT04913402 - Sufentanil Used by Paramedics to Treat Pain in Acute Trauma
Not yet recruiting NCT06070350 - Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children Phase 3
Recruiting NCT05616130 - Pathological Myeloid Activation After Sepsis and Trauma
Completed NCT05628519 - Captain Sonar Impact on Trauma Patient Management N/A
Recruiting NCT04907240 - Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
Recruiting NCT06123104 - Assessment of Automatic Tourniquets for Soldiers During Wartime N/A
Recruiting NCT05865327 - UltrasouNd-guided Percutaneous Intercostal Nerve Cryoneurolysis for Analgesia Following Traumatic Rib Fracture N/A
Completed NCT05175872 - Factors Affecting Mortality and Morbidity in Trauma Patients Followed in Intensive Care Unit
Not yet recruiting NCT04387305 - Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study Phase 3
Recruiting NCT04416412 - ICG Fluorescence Imaging in Open Fracture Trauma Patients
Completed NCT04080479 - Bolus Versus Continuous Enteral Tube Feeding N/A
Completed NCT04030832 - Reconstruction of Skin Substance Loss With "Micro-grafts" Obtained by Mechanical Disintegration
Active, not recruiting NCT06063434 - Testing the Effectiveness of Night Shift, a Theory-based Customized Video Game N/A
Not yet recruiting NCT04954768 - Epidemiological Characteristics of Elderly Trauma Patients in Zhejiang Province and Development of Geriatric Trauma Short-term Mortality Prediction Model
Completed NCT04327895 - Surgery in Context of Terrorist Attack : a Survey of French Surgeons
Completed NCT03888703 - The Use of Fractional Ablative CO2 Laser vs Control on Acute Traumatic Injuries to Prevent Scar Formation N/A